PriceSensitive

Three micro-cap stocks tracking cutting-edge technology

Cryptocurrency, Health Care, Industrial, Technology, Weekly Market Movers
04 August 2025 05:00 (EST)

Eye with circuitry. (Source: Adobe Stock. Generated by AI)

The potential for cutting-edge technology stocks to deliver exponential returns often leads investors astray, tempting them with the glamour of ownership to such a degree that any sense of valuation goes out the window.

This content has been prepared as part of a partnership with Cheelcare Inc., Nextech3D.AI Corp. and Fineqia International Inc., and is intended for informational purposes only.

This instinctual phenomenon, known in behavioral finance as herd mentality, can lead to unsustainable run-ups in valuation, where a company far outshoots its given technology’s tailwind, well beyond what its income statements can substantiate, opening investors up to steep losses once the company fails to keep up with expectations.

To avoid this outcome and populate their watchlists with an optimized candidate mix, it stands to reason that investors should keep blind belief at bay through a focus on fundamentals, grounding their exposure to cutting-edge technology in business health and long-term, high-conviction growth runways.

To get your watchlist started, in the newest edition of Stockhouse’s Weekly Market Movers, I’ll analyze three future-facing technology companies through a fundamental lens, revealing how each makes a data-driven case for a positive investment outcome.

Cheelcare

Our first technology stock to consider is Cheelcare, market capitalization C$20.02 million, an Ontario-based mobility technology developer catering to people with physical disabilities.

The company’s award-winning product suite includes cutting-edge robotic power wheelchairs, power add-ons for manual wheelchairs, as well as advanced wheelchair accessories such as a rearview camera, each designed to meaningfully enhance how users interact with the world.

Cheelcare is overseen by a management team specialized in software, medical devices, transportation, occupational therapy and capital raising, an ideal mix to keep operations aligned with client care and shareholder value in equal measure.

While the company listed on the TSXV only on July 16, and has yet to release its first public quarterly results, the stock seems to have normalized around the C$1 mark, following an initial pop, making it one to watch should the company translate the meeting of unmet needs among the wheelchair bound into evidence of a path to profitability. To this end, players in the global wheelchair market stand to benefit from a hefty 7.2 per cent compound annual growth rate through this decade, reaching US$8.4 billion in value by 2030.

Founder and chief executive officer (CEO), Eugene Cherny, spoke with Stockhouse’s Lyndsay Malchuk about the reasoning behind going public. Watch the interview here.

Cheelcare stock (TSXV:CHER) last traded at C$1.02 and has added 3.03 per cent since inception on July 16.

Nextech3D.AI

Our next cutting-edge technology stock with tangible potential, Nextech3D.AI, market capitalization C$13.67 million, specializes in AI-powered 3D modeling and spatial computing, helping a growing roster of enterprise and e-commerce clients – including Amazon and Shopify – drive engagement through scalable modeling, immersive product visualization and customizable digital spatial experiences.

The company recently released its financial results for the 15 months ended March 2025, showing robust evidence of being on a path to profitability, achieving:

According to Wednesday’s news release, management expects this efficiency to continue gaining traction over the near term thanks to a “cost structure aligned to support recurring revenue growth with reduced dependence on variable production models.” This cost structure, in turn, positions the company to “drive margin-accretive growth, capture recurring revenue opportunities and create long-term value for shareholders in fiscal 2025 and beyond.”

When we look farther back into Nextech’s income statements, we find evidence of this plan in motion, with reductions in SG&A expenses as well as long-term debt extending back to 2021, and net income loss improving every year from C$32.65 million in 2021 to C$5.18 million in the fiscal year ended December 2024.

The broader market vehemently disagrees, with Nextech3D.AI stock (CSE:NTAR) having given back 15 per cent year-over-year and 98.62 per cent since 2020, last trading at C$0.085, which should be making bells and whistles go off in the heads of readers that identify as contrarian investors.

Readers interested in learning more can check out Evan Gappelberg, Nextech3D.AI’s CEO, in conversation with Lyndsay Malchuk about the company’s progress at the intersection of AI, 3D modeling and e-commerce. Watch the interview here.

Fineqia

Our final boundary-pushing technology stock is Fineqia, market capitalization C$8.25 million, which is building a portfolio of investments and European-listed exchanged-traded products focused on blockchain and cryptocurrency, both key drivers towards a more equitable global financial system that strips power from institutions and reorients it towards the individual. Here’s a breakdown:

Fineqia differentiates itself from most pure-play crypto companies because it doesn’t have to rely exclusively on raising capital, taking on debt or selling assets to bankroll future growth plans. Rather, its funds generate management fees, providing it with a source of cash flow to take advantage of strategic opportunities and built revenue supported by crypto’s evolving but improving long-term growth prospects.

The company’s management team also brings clearly value-accretive experience to the table, with chairman Martin Graham serving as director of markets and head of AIM at the London Stock Exchange from 2003 to 2009, overseeing 1 in 4 of all global initial public offerings during his tenure, while CEO Bundeep Singh Rangar has long been active in the venture capital space with a focus on insurance and digital assets, attracting funding from the likes of Rakuten, Tim Draper, Madison Dearborn, Morgan Stanley, as well as the Thomson family of Thomson Reuters.

Despite a growing portfolio, revenue generation and executives deeply familiar with separating solid value propositions from story and hype, Fineqia stock (CSE:FNQ) is down by 50 per cent since 2020, last trading at C$0.005, presenting investors with a data-driven chance to transform broader market reluctance into the harvesting of substantial upside, contingent on blockchain and cryptocurrency settling into stable, long-term use cases.

Rangar joined Lyndsay Malchuk for episode 13 of Stockhouse’s Contributors Corner, where they cover the ins and outs of the ongoing shift towards corporate Bitcoin treasuries. Watch the interview here.

Thanks for reading! I’ll see you next week for a new edition of Weekly Market Movers, where I delve into companies that sat down with Stockhouse for an interview over the past week. Here’s the most recent article, in case you missed it.

Join the discussion: Find out what investors are saying about these cutting-edge technology stocks on the Cheelcare Inc., Nextech3D.AI Corp. and Fineqia International Inc. Bullboards and check out the rest of Stockhouse’s stock forums and message boards.

Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.


Related News